These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 28236991)

  • 1. [How to assess curative and/or preventive effects of psychotropic drugs?].
    Bottai T; Pringuey D; Belzeaux R; Adida M; Azorin JM
    Encephale; 2016 Dec; 42(6S):S33-S42. PubMed ID: 28236991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacology: the need for effectiveness trials to inform evidence-based psychiatric practice.
    Lagomasino IT; Dwight-Johnson M; Simpson GM
    Psychiatr Serv; 2005 Jun; 56(6):649-51. PubMed ID: 15939939
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxes of evidence in Russian addiction medicine.
    Mendelevich VD; Zalmunin KY
    Int J Risk Saf Med; 2015; 27 Suppl 1():S102-3. PubMed ID: 26639682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepped care: doing more with less?
    Davison GC
    J Consult Clin Psychol; 2000 Aug; 68(4):580-5. PubMed ID: 10965633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychotherapy and evidence-based medicine (EBM)--randomized controlled vs. naturalistic studies: is there only one gold standard?].
    Leichsenring F; Rüger U
    Z Psychosom Med Psychother; 2004; 50(2):203-17. PubMed ID: 15146395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
    Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
    Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social functioning and the treatment of depression.
    Weissman MM
    J Clin Psychiatry; 2000; 61 Suppl 1():33-8. PubMed ID: 10703761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
    Khanna R; Jariwala K; West-Strum D
    J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical issues on the use of network meta-analysis in psychiatry.
    Yildiz A; Vieta E; Correll CU; Nikodem M; Baldessarini RJ
    Harv Rev Psychiatry; 2014; 22(6):367-72. PubMed ID: 25377612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.
    Vieta E; Günther O; Locklear J; Ekman M; Miltenburger C; Chatterton ML; Åström M; Paulsson B
    Int J Neuropsychopharmacol; 2011 Sep; 14(8):1029-49. PubMed ID: 21733231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychotropic drugs in child and adolescent psychiatry].
    Rochet T; Revol O; Maillet J; de Villard R
    Ann Pediatr (Paris); 1993 Nov; 40(9):555-63. PubMed ID: 8279803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the cost effectiveness of newer psychotropic medications.
    Viale GL
    Am J Manag Care; 1997 Feb; 3 Suppl():S7-10. PubMed ID: 10180341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of different approaches to randomized clinical trials. Report on the 1987 MacArthur Foundation Network I Methodology Workshop.
    Kraemer HC; Pruyn JP
    Arch Gen Psychiatry; 1990 Dec; 47(12):1163-9. PubMed ID: 2147099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assuring that double-blind is blind.
    Perlis RH; Ostacher M; Fava M; Nierenberg AA; Sachs GS; Rosenbaum JF
    Am J Psychiatry; 2010 Mar; 167(3):250-2. PubMed ID: 20194487
    [No Abstract]   [Full Text] [Related]  

  • 18. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How sound is the double-blind design for evaluating psychotropic drugs?
    Fisher S; Greenberg RP
    J Nerv Ment Dis; 1993 Jun; 181(6):345-50. PubMed ID: 8501455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological and political issues in clinical pharmacology research by the year 2000.
    Carné X; Arnaiz JA
    Eur J Clin Pharmacol; 2000; 55(11-12):781-5. PubMed ID: 10805054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.